M&A Deal Summary

Agilent Acquires Resolution Bioscience

On March 2, 2021, Agilent acquired life science company Resolution Bioscience for 550M USD

Acquisition Highlights
  • This is Agilent’s 3rd transaction in the Life Science sector.
  • This is Agilent’s 6th largest (disclosed) transaction.
  • This is Agilent’s 26th transaction in the United States.
  • This is Agilent’s 1st transaction in Washington.

M&A Deal Summary
Date 2021-03-02
Target Resolution Bioscience
Sector Life Science
Buyer(s) Agilent
Deal Type Add-on Acquisition
Deal Value 550M USD

Target

Resolution Bioscience

Redmond, Washington, United States
Resolution Bioscience is a developer of a highly sensitive, non-invasive liquid biopsy platform that improves cancer diagnostics and monitoring for patients around the world. The company has developed and patented core technology for circulating cell-free DNA NGS analysis. Resolution Bioscience was founded in 2012 and is based in Redmond, Washington.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Agilent

Santa Clara, California, United States
Category Company
Founded 1999
Sector Test/Measurement Equipment
Employees17,600
Revenue 6.8B USD (2023)
DESCRIPTION
Entrance to Agilent's headquarters in Santa Clara, California.
Entrance to Agilent's headquarters in Santa Clara, California.

Agilent is a producer of solutions that includes instruments, software, services, and consumables for the entire laboratory workflow. Agilent's life sciences and applied markets business provide application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Agilent was founded in 1999 and is based in Santa Clara, California.

DEAL STATS #
Overall 33 of 38
Sector (Life Science) 3 of 6
Type (Add-on Acquisition) 30 of 35
State (Washington) 1 of 1
Country (United States) 26 of 28
Year (2021) 1 of 1
Size (of disclosed) 6 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-11 BioTek Instruments

Winooski, Vermont, United States

BioTek Instruments, Inc. is a designer, manufacturer, and distributor of innovative life science instrumentation. BioTek Instruments was founded in 1968 and is based in Winooski, Vermont.

Buy $1.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-17 Virtual Control

Hong Kong, China

Virtual Control is an AI and machine learning software developer that creates innovative analysis solutions in lab testing. Virtual Control was founded in 2017 and is based in Hong Kong, China.

Buy -
Mergr

Product

Company

Legal